top of page

Boston_H_color[33632]_edited.png

Search

Apr 28, 20221 min read

DLBCL: Unmet Needs in an Evolving Treatment Landscape ~ 5/18/22 @ Abe & Louie's

Interested? Email Todd directly at todd.boudreau@adctherapeutics.com.

Recent Posts

FREE! Multi-Institutional Educational Symposium ~ Thursday, October 10th

The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3

Unlocking the Potential for a Bispecific Antibody in 3L+ DLBCL and 3L+FL ~ Wednesday, October 23rd

Comments

bottom of page